Ghent University Academic Bibliography

Your filters: cql: author="Van Laethem, Jean-Luc" or (type any "bookEditor issueEditor" and editor="Van Laethem, Jea...

Add to list
- Journal Article
- A1
- open access
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer : a post hoc analysis of two non-randomized phase II trials

Nicolas Charette, Caroline Vandeputte, Lieveke Ameye, Camille Van Bogaert, Jonathan Krygier, Thomas Guiot, Amelie Deleporte, Thierry Delaunoit, Karen Geboes (UGent) , Jean-Luc Van Laethem, et al.

(2019) BMC CANCER. 19.
Add to list
- Conference Paper
- C3
Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer : preliminary analysis of the PePiTA study

Alain Hendlisz, Rafael Caparica, Amelie Deleporte, Jean-Luc Van Laethem, Philippe Vergauwe, Marc Van den Eynde, Guido Deboever, Jozef Janssens, Gauthier Demolin, Stephane Holbrechts, et al.

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(15, suppl.).
Add to list
- Conference Paper
- C3
High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib

Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Amelie Deleporte, Karen Geboes (UGent) , Thierry Delaunoit, Marc Peeters (UGent) , Gauthier Demolin, Lionel D'Hondt, et al.

(2018) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 36(15).
Add to list
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

Nicola Personeni, Laura Giordano, Giovanni Abbadessa, Camillo Porta, Ivan Borbath, Bruno Daniele, Jean-Luc Van Laethem, Hans Van Vlierberghe (UGent) , Joerg Trojan, Enrico N. De Toni, et al.

(2017) ONCOTARGET. 8(9). p.14408-14415
Add to list
- Conference Paper
- C3
Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)

Erwin Woff, Pashalina Kehagias, Caroline Vandeputte, Tarek Kamoun, Thomas Guiot, Lieveke Ameye, Karen Geboes (UGent) , Thierry Delaunoit, Gauthier Demolin, Marc Peeters (UGent) , et al.

(2017) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 35(Supplement 15).
Add to list
- Journal Article
- A1
- open access
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

Lorenza Rimassa, Giovanni Abbadessa, Nicola Personeni, Camillo Porta, Ivan Borbath, Bruno Daniele, Stefania Salvagni, Jean-Luc Van Laethem, Hans Van Vlierberghe (UGent) , Jörg Trojan, et al.

(2016) ONCOTARGET. 7(45). p.72622-72633
Add to list
- Conference Paper
- C3
Preoperative chemosensitivity testing as predictor of adjuvant benefit in stage III colon

Alain Hendlisz, Anne Deleporte, Jean-Luc Van Laethem, Philippe Vergauwe, Marc Van Den Eynde, Guy Deboever, Jos Janssens, Gauthier Demolin, Stephane Holbrechts, Marylène Clausse, et al.

(2014) ACTA GASTRO-ENTEROLOGICA BELGICA. 77(1).
Add to list
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digstive Oncology

Ivan Borbath, Antonio Ceratti, Chris Verslype, Anne Demols, Thierry Delaunois, Stéphanie Laurent (UGent) , Anne Deleporte, Peter Vergauwe, A Van Maanen, Christine Sempoux, et al.

(2013) ANNALS OF ONCOLOGY. 24(11). p.2824-2829
Add to list
- Journal Article
- A1
- open access
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study

Alain Hendlisz, Vassilis Golfinopoulos, Amelie Deleporte, Marianne Paesmans, Hazem El Mansy, Camilo Garcia, Marc Peeters, Lieven Annemans (UGent) , Caroline Vandeputte, Marion Maetens, et al.

(2013) BMC CANCER. 13.
Add to list
- Conference Paper
- C3
Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea

Alain Hendlisz, Marc Van Den Eynde, G Machiels, Isabel Dero, Karen Geboes (UGent) , Marc De Man, Koen Hendrickx, Thierry Delaunois, Els Monsaert, Eric Vanderstraeten, et al.

(2012) ACTA GASTRO-ENTEROLOGICA BELGICA. 75(1).

Academic Bibliography

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer : a post hoc analysis of two non-randomized phase II trials

Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer : preliminary analysis of the PePiTA study

High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib

Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

Preoperative chemosensitivity testing as predictor of adjuvant benefit in stage III colon

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digstive Oncology

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study

Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea

Contents

Support

Contact